Medicure (MCUJF) Gross Margin (2009 - 2026)

Medicure's Gross Margin history runs 18 years deep, the most recent figure standing at 44.31% for Q1 2026.

• On a quarterly basis, Gross Margin fell 754.0% year-over-year to 44.31% in Q1 2026; TTM through Mar 2026 was 39.69%, a 1580.0% decrease from a year earlier, with the FY2025 full-year figure at 40.71%, down 1903.0% from the prior year.
• Gross Margin advanced to 44.31% in Q1 2026 per MCUJF's latest filing, from 31.57% in the prior quarter.
• Across five years, Gross Margin topped out at 72.77% in Q3 2023 and bottomed at 31.57% in Q4 2025.
• The 5-year median for Gross Margin is 62.91% (2023), against an average of 58.61%.
• Across the five-year window, Gross Margin jumped 1018 bps in 2022 and slumped 2680 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 69.03% in 2022, then retreated by 0 bps to 69.03% in 2023, then dropped by 15 bps to 58.37% in 2024, then plunged by 46 bps to 31.57% in 2025, then surged by 40 bps to 44.31% in 2026.
• Per Business Quant, the three latest MCUJF Gross Margin figures stand at 44.31% (Q1 2026), 31.57% (Q4 2025), and 33.99% (Q3 2025).